Decisions granting marketing authorisations referred to in Article 5(1) shall be taken on the basis of the documents prepared in accordance with Article 33(1) and shall set out any conditions attached to the placing on the market of the veterinary medicinal product and the summary of the product characteristics (‘terms of the marketing authorisation’).
Déanfar cinntí lena ndeonaítear údaruithe margaíochta dá dtagraítear in Airteagal 5(1) ar bhonn na ndoiciméad arna n-ullmhú i gcomhréir le hAirteagal 33(1) agus leagfar amach iontu aon choinníollacha a bhaineann leis an táirge íocshláinte tréidliachta a chur ar an margadh agus an achoimre ar shaintréithe an táirge (“téarmaí an údaraithe margaíochta”).